An update on the medical treatment of Graves' hyperthyroidism

Michele Marinò, Francesco Latrofa, Francesca Menconi, Luca Chiovato, Paolo Vitti

Research output: Contribution to journalArticlepeer-review

Abstract

Medical treatment of Graves' hyperthyroidism is based on the use of thionamides; namely, methimazole and propylthiouracil. In the past, methimazole was preferred by European endocrinologists, whereas propylthiouracil was the first choice for the majority of their North American colleagues. However, because of the recent definition of a better side-effect profile, methimazole is nowadays the first choice world while. Although thionamides are quite effective for the short-term control of Graves' hyperthyroidism, a relatively high proportion of patients relapses after thionamide withdrawal. Other possible medical treatments, include iodine and compounds containing iodine, perchlorate, lithium (as an adjuvant in patients undergoing radioiodine therapy), β-adrenergic antagonists, glucocorticoids, and some new molecules still under investigation. Management of Graves' hyperthyroidism using thionamides as well as the other available medical treatments is here reviewed in detail, with a special mention of situations such as pregnancy and lactation, as well as neonatal and fetal thyrotoxicosis.

Original languageEnglish
Pages (from-to)1041-1048
Number of pages8
JournalAcademic Psychiatry
Volume37
Issue number11
DOIs
Publication statusPublished - Oct 24 2014

Keywords

  • Graves' disease
  • Hyperthyroidism
  • Methimazole
  • Propylthiouracil
  • Thyrotoxicosis

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Education

Fingerprint Dive into the research topics of 'An update on the medical treatment of Graves' hyperthyroidism'. Together they form a unique fingerprint.

Cite this